Evidence map›Paper›PMID 36364945›Full record

ArticleNutrients2022

Bioconverted Fruit Extract of Akebia Quinata Exhibits Anti-Obesity Effects in High-Fat Diet-Induced Obese Rats.

Seul Gi Lee, Eunbi Lee, Jongbeom Chae, Jin Soo Kim, Han-Saem Lee, Yu-Mi Lim, Jai-Hyun So, Dongyup Hahn, Ju-Ock Nam

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Therapeutic Effects ofInternational journal of molecular sciences · 2026
    Article
  2. Simultaneous Component Analysis ofPlants (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Therapeutic Candidates for Alzheimer's Disease: Saponins.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Seul Gi LeeDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.ORCID 0000-0001-8186-0886
Eunbi LeeDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Jongbeom ChaeDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.ORCID 0000-0002-1300-0101
Jin Soo KimDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Han-Saem LeeNational Development Institute of Korean Medicine, Gyeongsan-si 38540, Gyeongsangbuk-do, Korea.
Yu-Mi LimNational Development Institute of Korean Medicine, Gyeongsan-si 38540, Gyeongsangbuk-do, Korea.
Jai-Hyun SoNational Development Institute of Korean Medicine, Gyeongsan-si 38540, Gyeongsangbuk-do, Korea.
Dongyup HahnInstitute of Agricultural Science and Technology, Kyungpook National University, Daegu 41404, Korea.
Ju-Ock NamDepartment of Food Science and Biotechnology, Kyungpook National University, Daegu 41566, Korea.
Kyungpook National University · KRNational Development Institute of Korean Medicine · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Akebia quinata, commonly called chocolate vine, has various bioactivities, including antioxidant and anti-obesity properties. However, the anti-obesity effects of bioconverted extracts of A. quinate have not been examined. In this study, A. quinata fruit extracts was bioconverted using the enzyme isolated from the soybean paste fungi Aspergillus kawachii. To determine whether the bioconversion process could influence the anti-obesity effects of A. quinata fruit extracts, we employed 3T3-L1 adipocytes and HFD-induced obese rats. We observed that the bioconverted fruit extract of A. quinata (BFE) afforded anti-obesity effects, which were stronger than that for the non-bioconverted fruit extract (FE) of A. quinata. In 3T3-L1 adipocytes, treatment with BFE at concentrations of 20 and 40 μg reduced intracellular lipids by 74.8 (p < 0.05) and 54.9% (p < 0.01), respectively, without inducing cytotoxicity in preadipocytes. Moreover, the oral administration of BFE at the concentration of 300 mg/kg/day significantly reduced body and adipose tissue weights (p < 0.01) in HFD-induced obese rats. Plasma cholesterol values were reduced, whereas HDL was increased in BFE receiving rats. Although FE could exert anti-obesity effects, BFE supplementation induced more robust effects than FE. These results could be attributed to the bioconversion-induced alteration of bioactive compound content within the extract.

Indexed as

Anti-Obesity AgentsDiet, High-Fat3T3-L1 CellsAdipogenesisAnimalsFruitMiceMice, Inbred C57BLObesityPlant ExtractsRanunculalesRatsAnti-Obesity AgentsPlant Extracts3T3-L1 adipocytesAkebia quinateanti-adipogenicbioconversionchocolate vineobesity

Identifiers

PMID36364945
PMCPMC9656223
OpenAlexW4308325059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.